JAZZ - Latest News

Jazz Pharmaceuticals plc (JAZZ), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $15.39B. Trailing twelve-month P/E ratio is 16.46. Beta to the broader market is 0.32.

The article list below shows the most recent JAZZ headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent JAZZ Headlines

Jazz Pharmaceuticals Bolsters Epilepsy Division With Actio Biosciences Buyout

seekingalpha.com - Aug 12, 2026

Jazz Pharmaceuticals acquires Actio Biosciences for $820 million upfront, targeting rare KCNT1+ epilepsy with ABS-1230, a registrational-stage precisi

Jazz Pharmaceuticals to acquire Actio Biosciences for $820 million, expanding rare epilepsy portfolio

cnbc.com - Aug 11, 2026

Jazz Pharmaceuticals will acquire Actio Biosciences, Inc. for $820 million.

Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects

zacks.com - Aug 10, 2026

Explore Jazz's (JAZZ) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Jazz bets on epilepsy treatment with up to $1.32 billion deal for Actio

reuters.com - Aug 10, 2026

Jazz Pharmaceuticals said on Monday it would buy privately held Actio Biosciences in a deal valued at ​up to $1. 32 billion, adding an experimental tr

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

prnewswire.com - Aug 10, 2026

Adds ABS-1230, a clinical-stage, potential first-in-class precision therapy for KCNT1+ epilepsy Leverages Jazz development expertise and commercial st

How News Affects JAZZ Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track JAZZ's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked JAZZ news questions

What is the latest JAZZ news headline?

The most recent JAZZ headline (Aug 12, 2026) is "Jazz Pharmaceuticals Bolsters Epilepsy Division With Actio Biosciences Buyout". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the JAZZ news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What JAZZ news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual JAZZ options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.